PMID- 29702837 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20191120 IS - 2212-1102 (Electronic) IS - 2212-1099 (Linking) VI - 2 IP - 1 DP - 2013 May TI - Assessment of Adverse Events and Quality of Life of Cancer Patients in a Secondary Level Care, Rural Hospital in South India. PG - 103-106 LID - S2212-1099(13)00012-5 [pii] LID - 10.1016/j.vhri.2013.01.011 [doi] AB - OBJECTIVE: To grade adverse events (AEs) occurring after chemotherapy in the cancer patients and to explore the quality-of-life (QOL) findings among posttherapy cancer patients in a rural, secondary level care Indian hospital. METHODS: A cross-sectional study was carried out during a 6-month period in a rural secondary level care hospital situated at Anantapur district in South India. Patient and cancer demographics were collected from the cases treated in the study site. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 v 3.0 Telugu (regional language of the study site) module and Common Terminology Criteria for Adverse Events v 4.0 of Cancer Therapy Evaluation Program, USA, were used to assess the QOL and severity grades of AEs, respectively. RESULTS: Most AEs were mild or moderate, with only a few being severe. Insomnia (27.98%), nausea (13.50%), vomiting (12.81%), fatigue (10.90%), and pain (11.68%) were common, with insomnia being the most frequent. The different scores of the QOL scale (functional, symptomatic, financial, and global health status scores) were assessed independently. Among the functional scale parameters, the cognitive and physical functioning scores were good (85.14 and 82.79, respectively) and the social, emotional, and role functioning scores were moderate (77.94, 72.30, and 71.65, respectively). The overall effect of symptoms on QOL showed that the pain score was higher and interfered to a higher extent in patients (36.02) and the dyspnea score was the least and occurred to a lesser extent (7.20). But certain variables such as anorexia, for example, showed a greater interquartile range and SD, which implied that it gave a lesser chance for the prediction of results for that particular condition. Financial burden existed to a moderate level on an average in all the patients. CONCLUSIONS: The occurrence and severity of AEs was low, indicating that the patients tolerated and responded well to therapy. The survivorship is yet to be estimated and the life expectancy to be studied by further investigation of the subjects. CI - Copyright (c) 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved. FAU - Sowmya, S K R AU - Sowmya SKR AD - Department of Pharmacy Practice, Raghavendra Institute of Pharmaceutical Education & Research, Anantapur, AP, India. FAU - Thomas, Dixon AU - Thomas D AD - Department of Pharmacy Practice, Raghavendra Institute of Pharmaceutical Education & Research, Anantapur, AP, India. Electronic address: dixon.thomas@gmail.com. FAU - Zachariah, Seeba AU - Zachariah S AD - Department of Pharmacy Practice, Raghavendra Institute of Pharmaceutical Education & Research, Anantapur, AP, India. FAU - Daniel Sunad, Alexander AU - Daniel Sunad A AD - RDT Hospital, Bathalapalli, Anantapur, AP, India. LA - eng PT - Journal Article DEP - 20130315 PL - United States TA - Value Health Reg Issues JT - Value in health regional issues JID - 101592642 OTO - NOTNLM OT - CTCAE OT - EORTC-QLQ C30 OT - QOL OT - adverse events OT - chemotherapy EDAT- 2013/05/01 00:00 MHDA- 2013/05/01 00:01 CRDT- 2018/04/29 06:00 PHST- 2018/04/29 06:00 [entrez] PHST- 2013/05/01 00:00 [pubmed] PHST- 2013/05/01 00:01 [medline] AID - S2212-1099(13)00012-5 [pii] AID - 10.1016/j.vhri.2013.01.011 [doi] PST - ppublish SO - Value Health Reg Issues. 2013 May;2(1):103-106. doi: 10.1016/j.vhri.2013.01.011. Epub 2013 Mar 15.